移至標頭
移至導覽
移至內部
移至註腳
登入
幫助
English
研究資源
CUHK UPDates
論文庫
專家名錄
使用指引
關於我們
機構清單
> 心血管基因組醫學中心
主頁
研究成果
研究人員專頁
學系學部專頁
研究範圍
心血管基因組醫學中心
國家/地區
國家/地區
香港
研究人員
CHAN
,
To Kiu
KWOK
,
Ka Shing Maxwell
LAI
,
Angel
ONG
,
Sang Bing
POON
,
Ngar Yun Ellen
WU
,
Binbin
研究成果
Characterization of a novel mitophagy-related 5-genes signature for diagnosis of acute myocardial infarction
2024
)
Downregulation of Mitochondrial Fusion Protein Expression Affords Protection from Canonical Necroptosis in H9c2 Cardiomyoblasts
2024
)
Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity
2024
)
PEDF inhibits VEGF-induced vascular leakage through binding to VEGFR2 in acute myocardial infarction
2024
)
Anti-inflammatory effect of Danhong injection through inhibition of GSDMD-mediated pyroptosis
2023
)
Editorial: Myocardium regeneration and cardioprotection
2023
)
Harnessing mitochondrial transplantation to sustain cardiac function: Another step forward
2023
)
Large animal models of cardiac ischemia-reperfusion injury: Where are we now?
2023
)
Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor
2023
)
Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial
2023
)
The Calcineurin-Drp1-Mediated Mitochondrial Fragmentation Is Aligned with the Differentiation of c-Kit Cardiac Progenitor Cells
2023
)
Alteration of the N6-methyladenosine epitranscriptomic profile in synthetic phthalate-treated human induced pluripotent stem cell-derived endothelial cells
2022
)
Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
2022
)
Editorial: Organellar dynamics in cell fate
2022
)
Ischemic Preconditioning and Postconditioning Protect the Heart by Preserving the Mitochondrial Network
2022
)
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?
2022
)
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
2022
)
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell derived
cardiomyocytes
2022
)
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes
2022
)
Role of cardiac mitofusins in cardiac conduction following simulated ischemia–reperfusion
2022
)
Temporal Control of the WNT Signaling Pathway During Cardiac Differentiation Impacts Upon the Maturation State of Human Pluripotent Stem Cell Derived Cardiomyocytes
2022
)
Cell surface markers for immunophenotyping human pluripotent stem cell‑derived cardiomyocytes
2021
)
Circulating miR‐19b‐3p as a novel prognostic biomarker for acute heart failure
2021
)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
2021
)
Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications
2021
)
Mature human pluripotent stem cells derived cardiomyocytes to investigate cardiotoxicity induced by anti-cancer and anti-viral treatment
2021
)
Novel Cardiac Maturation Marker enables the Isolation of Mitochondria-rich Cardiomyocytes for Disease Modelling and Cardiotoxicity Testing
2021
)
Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2
2021
)
Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells
2020
)
Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT-AHF trial
2020
)
Generation of genomic-integration-free human induced pluripotent stem cells and the derived cardiomyocytes of X-linked dilated cardiomyopathy from DMD gene mutation
2020
)
Identification of the optimal source of human mesenchymal stromal cells for the treatment of Acute graft-versus-host disease
2020
)
Patient-derived induced pluripotent stem cells differentiated cardiomyocytes as platform for disease modelling For X-linked dilated cardiomyopathy
2020
)
The Cell Surface Marker CD36 Selectively Identifies Matured, Mitochondrial-rich hPSC-Cardiomyocytes
2020
)
Maturing the mitochondria: Human pluripotent stem cell-derived cardiomyocytes for disease modeling and drug screening
2019
)
Mitochondria-rich human pluripotent stem cell derived-cardiomyocytes with advanced metabolic properties uniquely recapitulate disease phenotype and drug responses
2019
)
Mitochondria-rich human pluripotent stem cell derived-cardiomyocytes with advanced metabolic properties uniquely recapitulate disease phenotype and drug responses
2019
)
分享連結
分享連結
您的名稱*
您的電子郵件*
收件者名稱*
收件者電子郵件*
訊息
Auxilliary Information
不會儲存任何資訊或與任何第三方分享資訊。
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy